| Don’t fear ‘fear conditioning’: Methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear TB Lonsdorf, MM Menz, M Andreatta, MA Fullana, A Golkar, J Haaker, ... Neuroscience & Biobehavioral Reviews 77, 247-285, 2017 | 962 | 2017 |
| Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. AT Gloster, HU Wittchen, F Einsle, T Lang, S Helbig-Lang, T Fydrich, ... Journal of consulting and clinical psychology 79 (3), 406, 2011 | 299 | 2011 |
| Neuropeptide S receptor gene—converging evidence for a role in panic disorder K Domschke, A Reif, H Weber, J Richter, C Hohoff, P Ohrmann, ... Molecular psychiatry 16 (9), 938-948, 2011 | 222 | 2011 |
| MAOA gene hypomethylation in panic disorder—reversibility of an epigenetic risk pattern by psychotherapy C Ziegler, J Richter, M Mahr, A Gajewska, MA Schiele, A Gehrmann, ... Translational psychiatry 6 (4), e773-e773, 2016 | 215 | 2016 |
| Navigating the garden of forking paths for data exclusions in fear conditioning research TB Lonsdorf, M Klingelhöfer-Jens, M Andreatta, T Beckers, A Chalkia, ... Elife 8, e52465, 2019 | 174 | 2019 |
| Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application U Lueken, KC Zierhut, T Hahn, B Straube, T Kircher, A Reif, J Richter, ... Neuroscience & Biobehavioral Reviews 66, 143-162, 2016 | 155 | 2016 |
| MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy A Reif, J Richter, B Straube, M Höfler, U Lueken, AT Gloster, H Weber, ... Molecular psychiatry 19 (1), 122-128, 2014 | 122 | 2014 |
| Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia AT Gloster, HU Wittchen, F Einsle, M Höfler, T Lang, S Helbig-Lang, ... European Archives of Psychiatry and Clinical Neuroscience 259 (Suppl 2), 155-166, 2009 | 119 | 2009 |
| Making translation work: Harmonizing cross-species methodology in the behavioural neuroscience of Pavlovian fear conditioning J Haaker, S Maren, M Andreatta, CJ Merz, J Richter, SH Richter, ... Neuroscience and biobehavioral reviews 107, 329, 2019 | 105 | 2019 |
| Change of threat expectancy as mechanism of exposure-based psychotherapy for anxiety disorders: Evidence from 8,484 exposure exercises of 605 patients A Pittig, I Heinig, S Goerigk, J Richter, M Hollandt, U Lueken, P Pauli, ... Clinical Psychological Science 11 (2), 199-217, 2023 | 97 | 2023 |
| Dynamics of defensive reactivity in patients with panic disorder and agoraphobia: implications for the etiology of panic disorder J Richter, AO Hamm, CA Pané-Farré, AL Gerlach, AT Gloster, ... Biological psychiatry 72 (6), 512-520, 2012 | 93 | 2012 |
| Panic disorder with agoraphobia from a behavioral neuroscience perspective: Applying the research principles formulated by the Research Domain Criteria (RDoC) initiative AO Hamm, J Richter, C Pané‐Farré, D Westphal, HU Wittchen, ... Psychophysiology 53 (3), 312-322, 2016 | 89 | 2016 |
| Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing H Weber, J Richter, B Straube, U Lueken, K Domschke, C Schartner, ... Molecular psychiatry 21 (6), 813-822, 2016 | 77 | 2016 |
| Experiential avoidance and anxiety sensitivity in patients with panic disorder and agoraphobia: Do both constructs measure the same? CK Kämpfe, AT Gloster, HU Wittchen, S Helbig-Lang, T Lang, AL Gerlach, ... International Journal of Clinical and Health Psychology 12 (1), 5-22, 2012 | 66 | 2012 |
| GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder J Deckert, H Weber, C Villmann, TB Lonsdorf, J Richter, M Andreatta, ... Molecular Psychiatry 22 (10), 1431-1439, 2017 | 64 | 2017 |
| Promoting long-term inhibition of human fear responses by non-invasive transcutaneous vagus nerve stimulation during extinction training C Szeska, J Richter, J Wendt, M Weymar, AO Hamm Scientific reports 10 (1), 1529, 2020 | 62 | 2020 |
| Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial A Pittig, I Heinig, S Goerigk, F Thiel, K Hummel, L Scholl, J Deckert, ... Depression and Anxiety 38 (11), 1169-1181, 2021 | 61 | 2021 |
| Optimizing exposure‐based CBT for anxiety disorders via enhanced extinction: Design and methods of a multicentre randomized clinical trial I Heinig, A Pittig, J Richter, K Hummel, I Alt, K Dickhöver, J Gamer, ... International journal of methods in psychiatric research 26 (2), e1560, 2017 | 60 | 2017 |
| The role of safety behaviors in exposure-based treatment for panic disorder and agoraphobia: Associations to symptom severity, treatment course, and outcome S Helbig-Lang, J Richter, T Lang, AL Gerlach, L Fehm, GW Alpers, ... Journal of anxiety disorders 28 (8), 836-844, 2014 | 58 | 2014 |
| The functional− 1019C/G HTR1A polymorphism and mechanisms of fear B Straube, A Reif, J Richter, U Lueken, H Weber, V Arolt, A Jansen, ... Translational Psychiatry 4 (12), e490-e490, 2014 | 55 | 2014 |
